- Home
- XAIR vs ADGM Comparison
XAIR vs ADGM Comparison
Compare XAIR & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- ADGM
- Stock Information
- Founded
- XAIR 2011
- ADGM 2011
- Country
- XAIR United States
- ADGM United States
- Employees
- XAIR N/A
- ADGM N/A
- Industry
- XAIR Medical/Dental Instruments
- ADGM
- Sector
- XAIR Health Care
- ADGM
- Exchange
- XAIR Nasdaq
- ADGM NYSE
- Market Cap
- XAIR 17.0M
- ADGM 19.7M
- IPO Year
- XAIR N/A
- ADGM N/A
- Fundamental
- Price
- XAIR $2.86
- ADGM $1.26
- Analyst Decision
- XAIR Strong Buy
- ADGM
- Analyst Count
- XAIR 3
- ADGM 0
- Target Price
- XAIR $23.67
- ADGM N/A
- AVG Volume (30 Days)
- XAIR 386.6K
- ADGM 45.0K
- Earning Date
- XAIR 08-12-2025
- ADGM 08-25-2025
- Dividend Yield
- XAIR N/A
- ADGM N/A
- EPS Growth
- XAIR N/A
- ADGM N/A
- EPS
- XAIR N/A
- ADGM N/A
- Revenue
- XAIR $3,705,000.00
- ADGM $576,000.00
- Revenue This Year
- XAIR $266.61
- ADGM N/A
- Revenue Next Year
- XAIR $140.76
- ADGM N/A
- P/E Ratio
- XAIR N/A
- ADGM N/A
- Revenue Growth
- XAIR 219.67
- ADGM 116.54
- 52 Week Low
- XAIR $2.75
- ADGM $0.63
- 52 Week High
- XAIR $13.52
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- XAIR 37.13
- ADGM N/A
- Support Level
- XAIR $2.93
- ADGM N/A
- Resistance Level
- XAIR $3.78
- ADGM N/A
- Average True Range (ATR)
- XAIR 0.26
- ADGM 0.00
- MACD
- XAIR -0.03
- ADGM 0.00
- Stochastic Oscillator
- XAIR 8.91
- ADGM 0.00
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.